METHODS: Chimeric 2S-albumins were produced in E. coli by replacing Ara h 2 domains with the corresponding ones from Ara h 6. After purification and refolding, secondary and tertiary structures of the chimeric proteins were assessed by CD-spectroscopy and by competitive inhibition of IgE-binding to native 2S-albumins. Allergenicity of chimeras was further assessed by IgE-binding measurements with sera from 11 peanut-allergic patients and by degranulation assay of RBL-SX 38 cells.
RESULTS: All chimeric constructions exhibited a proper refolding since cross-reactive IgE antibodies to Ara h 2 and Ara h 6 recognized the chimera with similar affinity. Moreover, IgE-binding measurements performed with sera displaying no significant IgE cross-reactivity between 2S-albumins permitted to locate major conformational epitopes of Ara h 2 between residues 30 and 88. Requirement of these conformational epitopes for an efficient mast cell degranulation was confirmed with sera from patients sensitized only to Ara h 2 or with sera depleted of Ara h 6-specific IgE antibodies.
CONCLUSIONS: Conformational cross-reactive epitopes of Ara h 2 and Ara h 6 were not impacted in chimeric 2S-albumins. Although the profile of epitopes recognition remained highly patient specific, the major conformational epitopes specific to Ara h 2 were located in the central domain.